Follow
Kevin Levine
Kevin Levine
Verified email at uw.edu
Title
Cited by
Cited by
Year
Mutation site and context dependent effects of ESR1 mutation in genome-edited breast cancer cell models
A Bahreini, Z Li, P Wang, KM Levine, N Tasdemir, L Cao, HM Weir, ...
Breast Cancer Research 19, 1-10, 2017
1402017
Drosophila Muller F Elements Maintain a Distinct Set of Genomic Properties Over 40 Million Years of Evolution
W Leung, CD Shaffer, LK Reed, ST Smith, W Barshop, W Dirkes, ...
G3: Genes, Genomes, Genetics 5 (5), 719-740, 2015
1062015
Invasive lobular and ductal breast carcinoma differ in immune response, protein translation efficiency and metabolism
T Du, L Zhu, KM Levine, N Tasdemir, AV Lee, DAA Vignali, BV Houten, ...
Scientific reports 8 (1), 1-11, 2018
1002018
Key regulators of lipid metabolism drive endocrine resistance in invasive lobular breast cancer
T Du, MJ Sikora, KM Levine, N Tasdemir, RB Riggins, SG Wendell, ...
Breast Cancer Research 20, 1-15, 2018
832018
WNT4 mediates estrogen receptor signaling and endocrine resistance in invasive lobular carcinoma cell lines
MJ Sikora, BM Jacobsen, K Levine, J Chen, NE Davidson, AV Lee, ...
Breast Cancer Research 18, 1-16, 2016
712016
Loss of E-cadherin Enhances IGF1–IGF1R pathway activation and sensitizes breast cancers to anti-IGF1R/InsR inhibitors
AM Nagle, KM Levine, N Tasdemir, JA Scott, K Burlbaugh, J Kehm, ...
Clinical Cancer Research 24 (20), 5165-5177, 2018
682018
Comprehensive phenotypic characterization of human invasive lobular carcinoma cell lines in 2D and 3D cultures
N Tasdemir, EA Bossart, Z Li, L Zhu, MJ Sikora, KM Levine, BM Jacobsen, ...
Cancer research 78 (21), 6209-6222, 2018
672018
A peroxidase peroxiredoxin 1-specific redox regulation of the novel FOXO3 microRNA target let-7
BL Hopkins, M Nadler, JJ Skoko, T Bertomeu, A Pelosi, PM Shafaei, ...
Antioxidants & redox signaling 28 (1), 62-77, 2018
632018
The Histone Database: an integrated resource for histones and histone fold-containing proteins
L Mariño-Ramírez, KM Levine, M Morales, S Zhang, RT Moreland, ...
Database 2011, 2011
622011
FGFR4 overexpression and hotspot mutations in metastatic ER+ breast cancer are enriched in the lobular subtype
KM Levine, N Priedigkeit, A Basudan, N Tasdemir, MJ Sikora, ES Sokol, ...
NPJ breast cancer 5 (1), 19, 2019
532019
FGFR4: A promising therapeutic target for breast cancer and other solid tumors
KM Levine, K Ding, L Chen, S Oesterreich
Pharmacology & therapeutics 214, 107590, 2020
482020
Functional characterization of lysine-specific demethylase 2 (LSD2/KDM1B) in breast cancer progression
L Chen, SN Vasilatos, Y Qin, TA Katz, C Cao, H Wu, N Tasdemir, ...
Oncotarget 8 (47), 81737, 2017
482017
Upregulation of IRS1 Enhances IGF1 Response in Y537S and D538G ESR1 Mutant Breast Cancer Cells
Z Li, KM Levine, A Bahreini, P Wang, D Chu, BH Park, S Oesterreich, ...
Endocrinology 159 (1), 285-296, 2018
432018
Single-cell transcriptomic heterogeneity in invasive ductal and lobular breast cancer cells
F Chen, K Ding, N Priedigkeit, A Elangovan, KM Levine, N Carleton, ...
Cancer research 81 (2), 268-281, 2021
362021
Hotspot ESR1 Mutations Are Multimodal and Contextual Modulators of Breast Cancer Metastasis
Z Li, Y Wu, ME Yates, N Tasdemir, A Bahreini, J Chen, KM Levine, ...
Cancer research 82 (7), 1321-1339, 2022
322022
Retrotransposons Are the Major Contributors to the Expansion of the Drosophila ananassae Muller F Element
W Leung, CD Shaffer, EJ Chen, TJ Quisenberry, K Ko, JM Braverman, ...
G3: Genes, Genomes, Genetics 7 (8), 2439-2460, 2017
242017
Proteomic and transcriptomic profiling identifies mediators of anchorage-independent growth and roles of inhibitor of differentiation proteins in invasive lobular carcinoma
N Tasdemir, K Ding, L Savariau, KM Levine, T Du, A Elangovan, ...
Scientific Reports 10 (1), 11487, 2020
192020
Differential regulation and targeting of estrogen receptor α turnover in invasive lobular breast carcinoma
S Sreekumar, KM Levine, MJ Sikora, J Chen, N Tasdemir, D Carter, ...
Endocrinology 161 (9), bqaa109, 2020
182020
SNAIL is induced by tamoxifen and leads to growth inhibition in invasive lobular breast carcinoma
EA Bossart, N Tasdemir, MJ Sikora, A Bahreini, KM Levine, J Chen, ...
Breast cancer research and treatment 175, 327-337, 2019
182019
Frequent amplifications of ESR1, ERBB2 and MDM4 in primary invasive lobular breast carcinoma
L Cao, A Basudan, MJ Sikora, A Bahreini, N Tasdemir, KM Levine, ...
Cancer letters 461, 21-30, 2019
162019
The system can't perform the operation now. Try again later.
Articles 1–20